Health Professional Radio - Podcast

Veronica Villanueva, a certified health coach, Cordon Bleu trained chef, and author of the book "The Grace of Cancer: Lessons in Humility and Greatness" shares her personal journey battling cancer, (beating it once, though she has recently found it has returned) and discusses the role CBD products and medicinal cannabis can have in the healing journey and offers key information to know when researching CBD products and medicinal cannabis. She notes that trying experimental therapy while refusing established treatments is dangerous. Veronica Villanueva discovered her "why" after being diagnosed with stage IV cancer in 2016. She knows she is alive today to share grace, blessings, and the lessons that cancer has taught her. Her "incurable" disease gave her the gift of knowing herself, loving herself, and sharing herself with others in a profound way. Through her work as a trained Cordon Bleu chef and certified health coach, Veronica aims to inspire others to embrace a holistic lifestyle built on a commitment t

Laine Richards, 18, shares her personal journey living with active epilepsy and how she went to Capitol Hill to speak with members of congress about the importance of epilepsy research and funding. For the past four years, she has represented the state of Michigan with the Epilepsy Foundation of America’s"Teens Speak Up!" program. Laine was recently awarded a $10,000 scholarship through the UCB Family Epilepsy Scholarship Program that offers scholarships to people living with epilepsy, family members, and caregivers. Despite living with daily seizures, Laine Richards has been an influential advocate for the Epilepsy Foundation of Michigan, personally raising more than $165,000 since she became involved with the organization. Laine is very active with the Foundation and has also represented the state of Michigan in the Epilepsy Foundation of America's “Teens Speak Up” program where she has lobbied on Capitol Hill annually to advocate for those living with epilepsy. Additionally, Laine is a proud recipient of

Dr. William Flood, Chief Medical Officer for Eviti at NantHealth, discusses new significant findings from Eviti Connect, presented at the San Antonio Breast Cancer Symposium 2020, around the adoption of trastuzumab biosimilars in the treatment of HER2-positive breast cancer. These findings show the promise of biosimilars as the oncology community continues to use them more to provide high-quality cancer care while lowering overall costs. Dr. William Flood is the Chief Medical Officer for Eviti at NantHealth, a provider of enterprise solutions that help businesses transform complex data into actionable insights. Prior to his role within NantHealth, Dr. Flood has served as Assistant in Oncology at the Johns Hopkins Oncology Center, Assistant Professor and Associate Professor of Medicine at the Penn State College of Medicine. He is a multi-time graduate of Penn State (with a bachelor's of science in molecular and cell biology and a master's in health evaluation sciences) and earned his medical degree from the

Returning guest, Dr. Len Friedland, VP and Director, Scientific Affairs and Public Health, Vaccines at GSK discusses meningococcal disease, symptoms, and the 2 different types of vaccines available for MenACWY and MenB. He is joined by meningitis survivor and GSK spokesperson, Jamie Schanbaum who shares her experience with meningococcal septicemia and who founded the J.A.M.I.E. Group (Joint Advocacy of Meningococcal Information & Education) in 2009 to help raise awareness about the impact of meningitis and the importance of vaccination. Dr. Len Friedland is a practicing physician, vaccine researcher, and Vice President and Director, Scientific Affairs and Public Health, Vaccines at GSK. Dr. Friedland has held many positions in clinical research and development with GSK since 2003, specializing in infectious disease vaccination. Prior to his work at GSK, Dr. Friedland was Division Chief, Pediatric Emergency Medicine at Temple University School of Medicine. Dr. Friedland studied medicine at Mount Sinai Sc

Rajni Dronamraju, Senior Director, Charitable Giving Strategy at Genentech, discusses Genentech’s ongoing efforts to address the impact of trauma, stress and racism on the health and well-being of low-income kids and families across the Bay Area. She also discusses the recent launch of the All In For Kids multi-donor fund to unite Bay Area nonprofits, advocates and leaders in advancing solutions that address childhood adversity and trauma. Genentech seeded the fund with $5M. Listeners can learn more at The Resilience Effect.

Antony Koblish, co-founder and CEO of TELA Bio, a medtech company focused on solving the issues related to hernia repair and soft tissue reconstruction, discusses OviTex®, a next generation mesh that features the safety and naturalness of biologic material and the strength and durability of synthetic mesh. TELA Bio worked with 100+ general and plastic surgeons to purposefully design a portfolio of soft-tissue repair solutions that provide a more natural hernia repair option. Antony Koblish is a medical device entrepreneur with 25 years of experience in health care. Prior to founding TELA Bio Mr. Koblish was President and Chief Executive Officer of Orthovita Inc. a publicly traded orthobiologics and biosurgery medical device company. During his tenure as Chief Executive Officer of Orthovita from 2002 to 2011 Mr. Koblish created significant company value growing valuation from $30M to a $316M exit sale to Stryker Corporation in 2011. He is a skilled leader with a proven track record in driving sales growth bui

Dr. Peter S. Tippett, founder and CEO of careMESH, a healthcare communication platform that enables hospitals and clinicians to securely share patient data with any other U.S. healthcare provider discusses how healthcare interoperability has changed over the years and how COVID accelerated the need for better patient-to-physician transfer of care. Dr. Peter S. Tippett is currently CEO of careMESH. He is a physician, scientist, business leader and technology entrepreneur with extensive risk management and health information technology expertise. One of his early startups created the first commercial antivirus product, Certus (which sold to Symantec and became Norton Antivirus). As a leader in the global information security industry (ICSA Labs, TruSecure, CyberTrust, Information Security Magazine), Tippett developed a range of foundational and widely accepted risk equations and models. He was a member of the President’s Information Technology Advisory Committee (PITAC) under G.W. Bush, and served with both

David Weaver, CEO of Aphex™ BioCleanse Systems, Inc. discusses the world’s first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology. The technology, called Hy-IQ® Water, has a unique method of action that uses hydrogen ions traveling at nearly the speed of light to breach the cell walls of exoskeleton germs. The company has filed to be the first FDA cleared non-alcohol hand sanitizer. Aphex has created other products that are safe for pets, can be used on vegetables and fruits, and in industrial and clinical settings. David Weaver holds over 40 years of experience in engineering and design and is responsible for the creation of much of Aphex’s proprietary formulas. Previously, he spent over two decades as an optical engineer for Eastman Kodak, where he earned a name for himself by streamlining the company’s technology and operations, training its team around the world and innovating for the photography industry. Following his role with Eastman Kodak, Weaver went on to found his own d

Sarah Cross, Ph.D., Associate Scientific Director, Women's Health, U.S. Medical Affairs at AbbVie discusses the newly formed Alliance for Endometriosis by seven women's health-focused organizations - AbbVie, the American College of Obstetricians and Gynecologists, Black Women’s Health Imperative,the Endometriosis Association,GE Healthcare,HealthyWomen and the International Pelvic Pain Society.  The goal of the alliance is to improve the lives of the one in 10 women of reproductive age living with endometriosis in the United States.The Alliance is actively seeking insights via a survey atAllianceForEndo.com and encouraging the endometriosis community to share their experiences to better understand their wants and needs. Sarah Cross, Ph.D., is an Associate Scientific Director, Women’s Health, U.S. Medical Affairs at AbbVie, and is responsible for leading the team’s endometriosis efforts. Sarah joined AbbVie in 2017 as a Women’s Health Medical Science Liaison for U.S. Medical Affairs. Prior to joining AbbVie, S

Dr. Douglas Rex, MD., Distinguished Professor Emeritus at Indiana University School of Medicine, discusses the recent (Nov 2020) U.S. FDA approval of Sebela Pharmaceuticals' SUTAB® Tablets (sodium sulfate, magnesium sulfate, and potassium chloride), a new, safe, and effective alternative to liquid colonoscopy prep solution. He worked as a lead principal investigator for the Phase 3 clinical trials of SUTAB Douglas K. Rex, M.D. is a Distinguished Professor Emeritus at Indiana University School of Medicine and a full-time clinical gastroenterologist at Indiana University Hospitals. He is a past President of the American College of Gastroenterology and the current President-elect of the American Society for Gastrointestinal Endoscopy.

Lead researcher, Dr. David Vossler, MD, FAAN FACNS FAES, Department of Neurology, University of Washington, discusses the recent U.S. FDA approval of UCB's VIMPAT® (lacosamide) CV as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older and VIMPAT injection for intravenous use in children four years of age and older. David Vossler, MD, holds his Doctor of Medicine degree, cum laude from Jefferson Medical College of Thomas Jefferson University, and Bachelor or Arts, magna cum laude from University of Rochester in Rochester, New York. He completed his Neurology Residency at Boston University in 1987. He completed an additional Fellowship in Clinical Neuro-physiology in 1989 at University of Washington. Dr. Vossler is the Medical Director of The Neuroscience Institute and a national authority on epilepsy and clinical neurophysiology. He has authored over 50 scientific articles and has served on journal editorial boards and boards of nati

Returning guest, Dr. Adriana Carrillo-Iregui, pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children's Hospital discusses immunotherapy for at risk children that is an emerging treatment for Type 1 diabetes. She explains how it works and which pediatric patients are candidates for this drug. Dr. Carrillo-Iregui is a pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital. Dr. Carrillo-Iregui received her medical degree at the Universidad El Bosque in Bogota, Colombia and completed a pediatric residency at Nicklaus Children’s Hospital followed by a fellowship in pediatric endocrinology at the University of Miami, Jackson Memorial Hospital. She is board certified in pediatrics and pediatric endocrinology. Before joining Nicklaus Children's she was an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at the University of Miami, Miller School of Medicine. Her research and clinical interest has focus

Dr. Amy Shapiro, hematologist-oncologist and CEO and co-medical director at the Indiana Hemophilia & Thrombosis Center, Inc., discusses important treatment developments that have brought hope to people living with hemophilia A. She is joined by Guy who is living with hemophilia A. Dr. Amy Shapiro, MD, is the co-founder, CEO and co-medical director at the Indiana Hemophilia & Thrombosis Center, Inc. A board-certified pediatric hematologist-oncologist, Dr. Shapiro received her medical degree in 1980 from the New York University School of Medicine. She was named "Physician of the Year” in 2001 by the National Hemophilia Foundation (NHF) and was honored with the Leadership in Research Award from NHF in 2017. Dr. Shapiro received the “Distinguished Hoosier Award” in 2009 from the State of Indiana, presented to her by Governor Mitch Daniels. She has also authored or co-authored over 120 articles and abstracts and eight textbook chapters.

Dr. Jessica Whelan, family psychiatric nurse practitioner discusses why the holiday season can be particularly challenging for people living with mental health conditions like bipolar I disorder, the difference between holiday blues and bipolar I disorder, and a treatment option people living with bipolar I disorder can discuss with their doctors. Visit www.vraylar.com to learn more including additional safety information. Dr. Jessica Whelan, DNP, BA, APRN, FPMHNP-BC, RN-BC. Dr. Jessica Whelan has extensive experience in the mental health field and has served as a speaker and advisory board member in the areas of nursing leadership, psychopharmacology, bipolar disorder, major depressive disorder, attention deficit disorder, schizophrenia, tardive dyskinesia, pseudobulbar affect, binge eating disorders, autism spectrum disorders, psychopharmacogenomics, epigenetics as well as genetic testing, to name a few. Dr. Whelan is the owner and CEO of a national network of clinicians with Holon Inclusive Health System

Returning guest, board-certified internist, Dr. Jacob Teitelbaum discusses a recent study published in the "American Journal of Clinical Pathology" (Nov 2020) that showed that 59 percent of patients with COVID-19 are vitamin D-deficient when they’re admitted; and the deficiency was most pronounced in men with advanced stages of COVID-related pneumonia. He also talks about the long term effects of COVID-19, known as “long-hauler syndrome" and his clinical work and research on post-viral energy depletion. Jacob Teitelbaum, M.D., is one of the most frequently quoted integrative,pain and fibromyalgia medical authorities in the world. He is the author of the best-selling From Fatigued to Fantastic!,Pain Free, 1,2,3!, the Complete Guide to Beating Sugar Addiction, Real Cause Real Cure,The Fatigue and Fibromyalgia Solution, Diabetes Is Optional and the popular free Smart Phone app Cures A-Z. He is the lead author of 5 studies on effective treatment for fibromyalgia and chronic fatigue syndrome, and a study on effe

Paul Hastings, CEO of Nkarta Therapeutics discusses results from their NKX101 study, an allogeneic CAR Natural Killer (NK) cell therapy, in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) or higher-risk myelodysplastic syndrome (MDS). Paul is the President and Chief Executive Officer of Nkarta, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer. After beginning his career in sales and marketing at Hoffman-LaRoche, he has led more than a dozen biopharma companies as CEO, President or Director. He currently serves as Vice Chair and member of the Executive Committee of BIO.

Dr. Riju Ray, MD, PhD, Senior Medical Lead at GSK, leading U.S. medical affairs across asthma and COPD, discusses a recent (Dec 2020) study funded by GSK and co-developed by GSK and CHEST as part of the CHEST "Clinical Perspectives" series evaluating the role of pulmonologists, COPD exacerbations, and the need to improve COPD management and education. Dr. Riju Ray is an MD/PhD senior medical lead within the Respiratory team at GSK US medical affairs leading teams across both Asthma and COPD. He is based out of Research Triangle Park in North Carolina. Prior to joining GSK Dr. Ray was an assistant professor at the University of Pennsylvania in Philadelphia. Dr. Ray has worked in clinical development leading clinical trials and medical affairs for GSK. He has worked across different therapeutic areas spanning Respiratory disease, Oncology, Neuroscience and Auto-immune diseases.

Dr. Adriana Carrillo-Iregui, pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children's Hospital discusses the TEDDY study (The Environmental Determinants of Diabetes in the Young), a national study to find out why type 1 diabetes mellitus (T1DM) is on the rise in children. Early data shows that genetic predisposition and environmental factors play a role in the cause of T1 diabetes. Dr. Carrillo-Iregui is a pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital. Dr. Carrillo-Iregui received her medical degree at the Universidad El Bosque in Bogota, Colombia and completed a pediatric residency at Nicklaus Children’s Hospital followed by a fellowship in pediatric endocrinology at the University of Miami, Jackson Memorial Hospital. She is board certified in pediatrics and pediatric endocrinology. Before joining Nicklaus Children's she was an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at th

Dr. C. Noel Bairey Merz, MD, Director of the Barbra Streisand Women's Heart Center, the Linda Joy Pollin Women's Heart Health Program, the Erika J. Glazer Women's Heart Research Initiative, and the Preventive Cardiac Center at the Smidt Cedars-Sinai Heart Institute discusses coronary microvascular dysfunction (CMD), and how to identify and assist patients living with CMD against the backdrop of a pandemic. She talks about what cardiologists and general practitioners should know about CMD and its warning signs, and the developing treatment options in the space.

Returning guest, Dr. Julie Harper, board-certified dermatologist and Galderma consultant, discusses maskne, seasonal acne and related treatment options. She also discusses the burden and stigma around acne and her experience treating acne via telehealth. Dr. Julie C. Harper, MD is a Birmingham, AL based board-certified dermatologist and Galderma consultant. She received her medical degree from the University of Missouri, Columbia School of Medicine, and went on to complete an internship in Internal Medicine. She completed her undergraduate degree at Southeast Missouri State University and her dermatology residency at the University of Missouri, Columbia.Dr. Harper is the founding director of the American Acne and Rosacea Society and is the organization’s immediate past-President. She is a Fellow of the American Academy of Dermatology and recently served on the AAD’s Acne Work Group, tasked with writing acne treatment guidelines. Dr. Harper is also a member of the Women’s Dermatological Society and a former